Travere Therapeutics

ISIN US89422G1076

WKN A2QHYP

Market cap (in EUR)

5,309 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR	5,309 m
EPS, EUR	-0.65
P/B ratio	250.5
P/E ratio	-
Dividend yield	0.00%

Income statement (2025)

Revenue, EUR	435 m
Net income, EUR	-45 m
Profit margin	-10.24%

What ETF is Travere Therapeutics in?

There are 36 ETFs which contain Travere Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Travere Therapeutics is the L&G Pharma Breakthrough UCITS ETF.

ETF	Weight	Investment focus	Fund size (in m EUR)
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc)	0.08%	Equity United States Small Cap	82
UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc	0.01%	Equity United States Multi-Factor Strategy	8
iShares Russell 2000 Swap UCITS ETF USD (Acc)	0.19%	Equity United States Small Cap	52
L&G Russell 2000 US Small Cap Quality UCITS ETF	0.38%	Equity United States Small Cap	190
Amundi Russell 2000 UCITS ETF EUR (C)	0.19%	Equity United States Small Cap	629
UBS MSCI USA Select Factor Mix UCITS ETF USD dis	0.01%	Equity United States Multi-Factor Strategy	29
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing	0.01%	Equity World Multi-Factor Strategy	245
iShares MSCI World Small Cap UCITS ETF	0.05%	Equity World Small Cap	7,895
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C	0.16%	Equity World Health Care Social/Environmental	25
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Dist	0.19%	Equity United States Small Cap	3
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF EUR Hedged (Acc)	0.19%	Equity United States Small Cap	146
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist)	0.05%	Equity World Small Cap	46
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF USD	0.19%	Equity United States Small Cap	4,226
ODDO BHF Global Equity Active UCITS ETF C	0.00%	Equity World Social/Environmental	8
Xtrackers MSCI Global Social Fairness Contributors UCITS ETF 1C	0.03%	Equity World Social/Environmental	3
Amundi Russell 2000 UCITS ETF USD	0.19%	Equity United States Small Cap	217
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Acc)	0.00%	Equity World	8,306
UBS MSCI USA Select Factor Mix UCITS ETF USD acc	0.01%	Equity United States Multi-Factor Strategy	114
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Acc)	0.05%	Equity World Small Cap	1,736
Xtrackers Russell 2000 UCITS ETF 1C	0.19%	Equity United States Small Cap	1,977
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Dist)	0.00%	Equity World	239
UBS MSCI USA Select Factor Mix UCITS ETF hCHF acc	0.01%	Equity United States Multi-Factor Strategy	24
Xtrackers MSCI Global SDGs UCITS ETF 1C	0.13%	Equity World Social/Environmental	6
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc)	0.08%	Equity United States Small Cap	2,478
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF CHF Hedged (acc)	0.08%	Equity United States Small Cap	34
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Acc	0.19%	Equity United States Small Cap	11
Invesco Nasdaq Biotech UCITS ETF	0.40%	Equity United States Health Care Biotech	439
iShares Russell 2000 Swap UCITS ETF EUR Hedged (Acc)	0.19%	Equity United States Small Cap	82
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.40%	Equity United States Health Care Biotech	71
Invesco Russell 2000 UCITS ETF Acc	0.19%	Equity United States Small Cap	300
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating	0.01%	Equity World Multi-Factor Strategy	1,493
iShares Nasdaq US Biotechnology UCITS ETF	0.40%	Equity United States Health Care Biotech	1,041
Xtrackers MSCI World IMI UCITS ETF 1C Capitalisation	0.00%	Equity World	24
ODDO BHF Global Equity Active UCITS ETF Acc - CGP	0.00%	Equity World Social/Environmental	0
L&G Pharma Breakthrough UCITS ETF	5.58%	Equity World Health Care Innovation	25
UBS MSCI World Small Cap UCITS ETF USD acc	0.05%	Equity World Small Cap	41

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.

Select your savings amount:

Broker	Rating	Execution fee	Account fee
		0.00 CHF	0.00 CHF	View offer*

Detailed comparison of all offers

Source: justETF Research; as of 10/2026. The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable AG. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.

Change your settings